نتایج جستجو برای: subutex
تعداد نتایج: 113 فیلتر نتایج به سال:
S45 Fallenberg E.M.: Advisory Board; Bayer. Research/Grant Support; GE Healthcare, Siemens Healthcare, Bayer. Speaker; GE Healthcare, Siemens Healthcare, Bayer. Froehlich J.M.: Consultant; Guerbet. Frydrychowicz A.: Research/Grant Support; Scientific stipend Bracco Diagnostics. Other; The University of Wisconsin Madison receives research support from GE Healthcare. Fürst S.: Employee; B.W. Jako...
Affi liations: From the Department of Pharmacy (Drs Ogale and Sullivan), University of Washington; the Center for Management of Complex Chronic Care (Dr Lee), Edward Hines Jr VA Hospital; and the Center for Pharmacoeconomic Research, Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL. Dr Ogale is currently at Genentech, Inc. Financial nonfi nancial disclosures: The ...
INTRODUCTION Dipeptidyl peptidase-4 (DPP-4) inhibitors including alogliptin are categorised as a newer class of oral hypoglycaemic, antidiabetic drugs to suppress the degradation of incretin hormones ((glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)) by DPP-4. We have scheduled a large-scale, multicentre, prospective, observational study (Japan-Based clini...
s of papers presented at the International Symposium on Laboratory Automation and Robotics (October 1992) Keynote 1: Practical aspects of laboratory automation in pharmaceutical development Eugene J. McGonigle, Schering-Plough Research Institute, Kenilworth, NJ An early perception of laboratory automation was ’automated analysis’ and its focus on the manipulative aspects of analytical chemistry...
Mechanism of Action: Dolutegravir inhibits the catalytic activity of HIV integrase, which is an HIV encoded enzyme required for viral replication. Integrase is one of the three HIV-1 enzymes required for viral replication. Integration of HIV into cellular DNA is a multi-step process. First, the assembly of integrase in a stable complex with the viral DNA occurs. Second, the terminal dinucleotid...
BACKGROUND In patients with chronic infection with hepatitis C virus (HCV) genotype 1 who do not have a sustained response to therapy with peginterferon-ribavirin, outcomes after retreatment are suboptimal. Boceprevir, a protease inhibitor that binds to the HCV nonstructural 3 (NS3) active site, has been suggested as an additional treatment. METHODS To assess the effect of the combination of ...
PURPOSE Generic substitution of brand-name medications can lead to significant cost savings and is an accepted medical practice. This study evaluated clinical and safety outcomes among liver transplant recipients whose mycophenolate mofetil (MMF) was converted from the brand-name formulation (Cellcept) to a generic formulation (My-rept). METHODS Clinical data from multiple centers were prospe...
Direct-acting antivirals (DAAs) are either part of the current standard of care or are in advanced clinical development for the treatment of patients chronically infected with hepatitis C virus (HCV) genotype 1, but concern exists with respect to the patients who fail these regimens with emergent drug-resistant variants. In the present study, ultradeep sequencing was performed to analyze resist...
BACKGROUND Vasomotor symptoms and bone loss are complications frequently induced by adjuvant treatment for breast cancer. Tibolone prevents both side-effects, but its effect on cancer recurrence is unknown. The aim of this study was to show non-inferiority of tibolone to placebo regarding risk of recurrence in breast-cancer patients with climacteric complaints. METHODS Between July 11, 2002, ...
A colorful ruling by federal U.S. District Court Judge Patti B. Saris (Boston) dated June 21, 2007, proclaimed that some pharmaceutical manufacturers had been “unscrupulously taking advantage of the flawed AWP (average wholesale price) system . . . by establishing secret mega-spreads far beyond the standard industry markup,” describing this behavior as “unethical and oppressive.” The case invol...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید